Postoperative Intensity-Modulated Radiotherapy in Low-Risk Endometrial Cancers: Final Results of a Phase I Study

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 5, 2010, Pages 1390-1395

  Macchia, Gabriella ^a   Cilla, Savino ^a   Ferrandina, Gabriella ^a   Padula, Gilbert D A ^b   Deodato, Francesco ^a   Digesù, Cinzia ^a   Caravatta, Luciana ^a   Picardi, Vincenzo ^a   Corrado, Giacomo ^a   Piermattei, Angelo ^a   Valentini, Vincenzo ^c   Cellini, Numa ^c   Scambia, Giovanni ^c   Morganti, Alessio Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Saint Mary's Health Care   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Endometrial cancer; IMRT; Vaginal vault

Indexed keywords

CLINICAL TARGET VOLUMES; CLINICAL TRIAL; CT SIMULATION; DOSE LEVELS; DOSE LIMITING TOXICITY; ENDOMETRIAL CANCER; FIELD INTENSITY; INTENSITY-MODULATED RADIOTHERAPY; INVERSE PLANNING; LOCAL RECURRENCE; MAXIMUM TOLERATED DOSE; PHASE I; PHASE II; PLANNING TARGET VOLUMES; RADIO-OPAQUE; SHORT-COURSE RADIOTHERAPY; TUMOR SIZE;

PHYSICAL THERAPY; TARGETS; TOXICITY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTITIS; DEFECATION DISORDER; DYSURIA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; GASTROINTESTINAL TOXICITY; HEMORRHOID; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PERIPHERAL EDEMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; SIMULATION; SKIN TOXICITY; TREATMENT PLANNING; TUMOR VOLUME; URINARY URGENCY; UROGENITAL TRACT DISEASE; VAGINITIS;

ADENOCARCINOMA; AGED; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAXIMUM TOLERATED DOSE; MIDDLE AGED; POSTOPERATIVE PERIOD; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 77949554098     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.091     Document Type: Article

References (39)

1. Price J.J., Hahn G.A., and Rominger C.J. Vaginal involvement in endometrial carcinoma. Am J Obset Gynecol 91 (1965) 1060-1065
2. Rutledge F.N., Tan S.K., and Fletcher G.H. Vaginal metastases from adenocarcinoma of the corpus uteri. Am J Obstet Gynecol 75 (1958) 167-174
3. Roberts J.A., Brunetto V.L., Keys H.M., et al. A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma. (GOG 99) (Abstr.). In: Society of Gynecologic Oncologists, 29th Annual Meeting. Gynecol Oncol 68 (1998) 135 (abs 298)
4. Chadha M., Nanavati P.J., Liu P., et al. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 75 (1999) 103-107
5. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 (2000) 1404-1411
6. Morrow C.P., Bundy B., Kurman R.J., et al. Relationship between surgery-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
7. Kadar N., Malfetano J.H., and Homesley H.D. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: Implications for therapy. Obstet Gynecol 80 (1992) 655-659
8. Aalders J., Abeler V., Kolstad P., et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol 56 (1980) 419-428
9. Ambros R.A., and Kurman R.J. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 69 (1992) 1424-1431
10. Gal D., Recio F.O., Zamurovic D., et al. Lymphvascular space involvement-a prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 42 (1991) 142-145
11. Greven K.M., Corn B.W., Case D., et al. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?. Int J Radiat Oncol Biol Phys 39 (1997) 413-418
12. National Cancer Institute. PDQ®-NCI's comprehensive cancer database. Available at: http://www.cancer.gov/cancerinfo/PDQ/cancerdatabase. Accessed Feb 9, 2009.
13. National Comprehensive Cancer Network. Clinical practice guidelines in oncology, v.2. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Feb 9, 2009.
14. Gretz III H.F., Economos K., Husain A., et al. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol 61 (1996) 409-415
15. Bond W.H. Early uterine body carcinoma: Has postoperative vaginal radiation any value?. Clin Radiol 36 (1985) 619-623
16. Elliot P., Green D., Coates A., et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer 4 (1994) 84-93
17. Joslin C.A., Vaishampayan G.V., and Malik A. The treatment of early cancer of the corpus utery. Br J Radiol 50 (1977) 38-45
18. Eltabbakh G.H., Piver M.S., Hempling R.E., et al. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial. Int J Radiat Oncol Biol Phys 38 (1997) 373-380
19. Alektiar K.M., McKee A., Venkatraman E., et al. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer. Int J Radiat Oncol Biol Phys 53 (2002) 707-713
20. Alektiar K.M., Venkatraman E., Chi D.S., et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 62 (2005) 111-117
21. Jolly S., Vargas C., Kumar T., et al. Vaginal brachytherapy alone: An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 97 (2005) 887-892
22. Solhjem M.C., Petersen I.A., and Haddock M.G. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1379-1384
23. Mollà M., Escude L., Nouet P., et al. Fractionated stereotactic radiotherapy boost for gynecologic tumors: An alternative to brachytherapy?. Int J Radiat Oncol Biol Phys 62 (2005) 118-124
24. Mundt A.J., Lujan A.E., Rotmensch J., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52 (2002) 1330-1337
25. Roeske J.C., Lujan A., Rotmensch J., et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48 (2000) 1613-1621
26. Ahamad A., and Jhingran A. New radiation techniques in gynecological cancer. Int J Gynecol Cancer 14 (2004) 569-579
27. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 261-266
28. Wahab S.H., Malyapa R.S., Mutic S., et al. A treatment planning study comparing HDR and AGIMRT for cervical cancer. Med Phys 31 (2004) 734-743
29. Roeske J.C., Lujan A., Rotmensch J., et al. A feasibility study of IMRT for the treatment of cervical cancer patients unable to receive intracavitary brachytherapy. In: Enderle J.D. (Ed). 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (2000), EEE Publications, Los Alamitos, CA 463-465
30. Guerrero M., Li X.A., Ma L., et al. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: Radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys 62 (2005) 933-939
31. Kavanagh B.D., Schefter T.E., Wu Q., et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 12 (2002) 260-271
32. Aydogan B., Mundt A.J., Smith B.D., et al. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys 65 (2006) 266-273
33. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0 (2003), National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD
34. Withers H.R., Thames H.D., and Peters L.J. A new isoeffect curve for change in dose per fraction. Radiat Oncol 1 (1983) 187-191
35. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
36. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336 (1997) 980-987
37. Nag S., Erickson B., Parikh S., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 48 (2000) 779-790
38. Nag S., and Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 46 (2000) 507-513
39. Hall E.J., and Wuu C.S. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88